A resolution designating July 21, 2021, as "Glioblastoma Awareness Day".

Bill 117 sres 210, also known as the resolution designating July 21, 2021, as "Glioblastoma Awareness Day," was introduced in the US Senate to bring attention to the devastating effects of glioblastoma, a rare and aggressive form of brain cancer. The resolution aims to raise awareness about the disease, honor those who have been affected by it, and support efforts to find a cure.

Glioblastoma is a particularly challenging form of cancer, with a low survival rate and limited treatment options. By designating a specific day to raise awareness about glioblastoma, this resolution seeks to educate the public about the disease and encourage support for research and treatment efforts.

The resolution emphasizes the importance of early detection, access to quality care, and ongoing research to improve outcomes for patients with glioblastoma. It also recognizes the courage and resilience of individuals and families facing this difficult diagnosis. Overall, Bill 117 sres 210 serves as a reminder of the urgent need to address the challenges posed by glioblastoma and to support those affected by this devastating disease. By designating July 21, 2021, as "Glioblastoma Awareness Day," the resolution aims to bring attention to this important issue and inspire action to improve outcomes for patients with glioblastoma.